Post-Stroke Optimization of Walking Using Explosive Resistance
POWER-D
2 other identifiers
interventional
48
1 country
1
Brief Summary
The investigators will study the effects of a 12 week strength training program on individuals who have had a stroke and are depressed to see if this type of exercise training helps treat depression and improves walking function. Our goal is to use the information collected in this study to help design treatments for people who have had a stroke that will help with many of the common consequences of stroke, including depression, muscle weakness and slow walking. Progress toward overcoming some of these issues would be incredibly valuable to any person who has had a stroke and their families.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2 stroke
Started Feb 2019
Longer than P75 for phase_2 stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 29, 2019
CompletedFirst Posted
Study publicly available on registry
February 1, 2019
CompletedStudy Start
First participant enrolled
February 6, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 12, 2024
CompletedResults Posted
Study results publicly available
April 24, 2025
CompletedApril 24, 2025
April 1, 2025
5.1 years
January 29, 2019
March 10, 2025
April 22, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Mean Score of Depression as Assessed by the Hamilton Rating Scale for Depression
The HAM-D is a clinician-rated scale with scores based on clinical interview and family report. It addresses both somatic and psychological symptoms of depression. Items are rated on either a 5-point scale (0 to 4) or 3-point scale (0 to 2), where higher scores represent increasing severity of depression. The scores of the 17 items are summed to obtain a total score (minimum score: 0, maximum score: 52).
Visit 1 through visit 24 (up to 12 weeks)
Secondary Outcomes (1)
Change in Self Selected Walking Speed
Visit 1 through visit 24 (up to 12 weeks)
Study Arms (2)
POWER training
EXPERIMENTALhigh velocity strength training
Stretching
ACTIVE COMPARATORUpper and lower body range of motion exercises
Interventions
Eligibility Criteria
You may qualify if:
- age 50-70
- stroke within the past 6 to 60 months
- residual paresis in the lower extremity (Fugl-Meyer LE motor score \<34)
- ability to walk without assistance and without an AFO during testing and training at speeds ranging from 0.2-0.8 m/s
- no antidepressant medications or no change in doses of psychotropic medication for at least 4 weeks prior to the study (6 weeks if newly initiated medication)
- HRSD question #9 regarding suicide \<2; and 7) provision of informed consent.
You may not qualify if:
- Unable to ambulate at least 150 feet prior to stroke, or experienced intermittent claudication while walking
- history of congestive heart failure, unstable cardiac arrhythmias, hypertrophic cardiomyopathy, severe aortic stenosis, angina or dyspnea at rest or during ADL's
- History of COPD or oxygen dependence
- Preexisting neurological disorders, dementia or previous stroke
- History of major head trauma
- Legal blindness or severe visual impairment
- history of psychosis or other Axis I disorder that is primary
- Life expectancy \<1 yr.
- Severe arthritis or other problems that limit passive ROM
- History of DVT or pulmonary embolism within 6 months
- Uncontrolled diabetes with recent weight loss, diabetic coma, or frequent insulin reactions
- Severe hypertension with systolic \>200 mmHg and diastolic \>110 mmHg at rest
- attempt of suicide in the last 2 years or at suicidal risk assessed by SCID interview
- History of seizures or currently prescribed anti-seizure medications
- Current enrollment in a clinical trial to enhance motor recovery
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Chris Gregory
- Organization
- Medical University of South Carolina
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 29, 2019
First Posted
February 1, 2019
Study Start
February 6, 2019
Primary Completion
March 15, 2024
Study Completion
May 12, 2024
Last Updated
April 24, 2025
Results First Posted
April 24, 2025
Record last verified: 2025-04